The Effects of a Rhythm and Music-based Therapy Program and Therapeutic Riding in Late Recovery Phase Following Stroke

April 23, 2019 updated by: Göteborg University

The initiative to the study is based on the fact that various forms of enriched environments and multimodal stimulation are found to have positive influences on motivation and psychosocial well-being and have been shown to facilitate multiple processes in the brain leading to structural regeneration and functional recovery. Since there is a lack of rehabilitation programs that encompass all dimensions of a stroke survivor's life researchers agree upon the need for a rehabilitation program that addresses both the social and physical needs of the patients. The aim with the project is to investigate whether it is possible to improve the life situation among patients with a history of stroke through a rhythm and music method and therapeutic riding. To get insights in the underlying mechanisms our research also focuses on relevant physiological, neurobiological and psychosocial mechanisms induced by the interventions. The hypothesis is that both treatment methods will mainly enhance participants' degree of participation.

The study is a randomized controlled trial where about 123 participants (50-75 years old) who had their stroke incident 1 - 5 years ago will be consecutively included and randomly allocated to the following three groups: a) Ronnie Gardiner Rhythm Music Method (RGRM) b) therapeutic riding c) a control group receiving RGRM after 9 months. Treatment proceeds during 12 weeks and evaluation takes place pre- and post intervention, and 12 and 24 weeks after the treatment is finalized. The evaluation consists of a thorough neuropsychological assessment, a physiotherapeutic assessment, sampling of blood and questionnaires covering mental, psychosocial, physical and psychological well-being. Interviews are also conducted in order to map the participants' experiences from the two treatment programs. Specially designed interviews are also planned to be carried through with participants having aphasia.

So far, there is only empirical support suggesting that RGRM has positive effects for individuals with a history of stroke making it significant to carry out research with the aim to contribute to strengthening the evidence of the method. A positive outcome would increase the scientific basis for this alternative treatment thus facilitating further research and implementation in everyday clinical practice.

Study Overview

Detailed Description

Background and Purpose: Treatments that improve function in late phase after stroke are urgently needed. We assessed whether multimodal interventions based on rhythm-and-music therapy or horse-riding therapy could lead to increased perceived recovery and functional improvement in a mixed population of individuals in late phase after stroke.

Methods: Participants were assigned to rhythm-and-music therapy, horse-riding therapy, or control using concealed randomization, stratified with respect to sex and stroke laterality. Therapy was given twice a week for 12 weeks. The primary outcome was change in participants' perception of stroke recovery as assessed by the Stroke Impact Scale with an intention-to-treat analysis. Secondary objective outcome measures were changes in balance, gait, grip strength, and cognition. Blinded assessments were performed at baseline, postintervention, and at 3- and 6-month follow-up.

Results: One hundred twenty-three participants were assigned to rhythm-and-music therapy (n=41), horse-riding therapy (n=41), or control (n=41). Post-intervention, the perception of stroke recovery (mean change from baseline on a scale ranging from 1 to 100) was higher among rhythm-and-music therapy (5.2 [95% confidence interval, 0.79-9.61]) and horse-riding therapy participants (9.8 [95% confidence interval, 6.00-13.66]), compared with controls (-0.5 [-3.20 to 2.28]); P=0.001 (1-way ANOVA). The improvements were sustained in both intervention groups 6 months later, and corresponding gains were observed for the secondary outcomes.

Conclusions: Multimodal interventions can improve long-term perception of recovery, as well as balance, gait, grip strength, and working memory in a mixed population of individuals in late phase after stroke.

Study Type

Interventional

Enrollment (Actual)

123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden
        • Sahlgrenska University hospital / Högsbo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 50 - 75 years
  • Disability grade 2 or 3 on MRS*)
  • Being in the late-phase of stroke (1 - 5 years after an ischemic or hemorrhagic stroke)
  • Ability to understand written and oral information and instructions in Swedish
  • Having an own housing
  • Ability to travel to the place of intervention and evaluation
  • No need for personal assistance in activities of daily living while participating in the treatment (going to the toilet, transport/transportation services for disabled, walking)

Exclusion Criteria:

  • Disability rated ˂ 2 or ˃ 3 on MRS*)
  • Pronounced fear of horses or allergy constituting a risk for the patients to participate in the therapeutic riding
  • Heart conditions that constitutes a risk for the individual to participate in the interventions
  • Non-controlled epileptic seizures constituting a risk for the patients to participate in the intervention
  • Lack of cognitive and/or verbal ability that makes it difficult for the individual to understand instructions and/or evaluation
  • Total paralysis of the affected arm
  • Injury or disease that makes the individual not suitable for the trial
  • Weight ˃ 95 kg (in order to spare the horses)
  • Having more than a half-time employment
  • Injury, disease or addiction that make the individual not suitable for the trial
  • Participation in RGRM or therapeutic riding during the year prior to inclusion
  • Having an additional stroke within the past year (TIA is however accepted)
  • Lack of willingness to participate in both treatment methods
  • Living ˃ 80 km from Gothenburg
  • Dependent on transportation services for disabled across the community border which is not allowed according to the regulation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rhythm and music therapy
Since 1993 The RGRM Method is a concept launched in both health and medical care. The method is mainly designed to help people with injuries and diseases of the central nervous system.
RGRM is multi-sensory method. The group including 6-8 participants is headed by a certified therapist of the method using a unique note system. The Note system is the combined body of body symbols in red and blue, with the audio codes and movements and be assembled in countless combinations to stimulate different parts of the brain. The movements are exercised by the hands tapping on the knees and feet stamping on the floor without the need for tools other than the body. The RGRM is developed to stimulate mobility, reading and speech, rhythm-esteem, body image, balance, memory, coordination, motor skills, concentration, perseverance and social skills. The group will have two sessions per week during 12 weeks.
Other Names:
  • The Ronnie Gardiner Rhythm Music Method (RGRM)
Active Comparator: Therapeutic riding
Therapeutic riding can be useful for individuals with neurological and muscular impairments. The goal of therapeutic riding as professional treatment is to improve neurological functioning and to achieve functional gains and enhance life skills.
The horses walk provides sensory input through movement, which is variable, rhythmic, and repetitive. The many textures, sounds, sights, movement experiences of working around a horse provide an enriched sensory environment. The participants gain from the physical benefits of being on a moving horse and are socially and emotionally stimulated by interacting with a horse and the rest of the group. The intervention is headed by educated therapists (occupational therapist and physical therapist), in conjunction with experienced horse handler and specially trained therapy horses. The treatment is held in group format (4-6 participants) twice per week in 12 weeks which runs in sessions where two participants ride at the same time.
Other: Receives no intervention
Receives no intervention and acts as a control group in the analyses but will receive rhythm and music therapy after one year, when the long-term follow-up is completed.
Receives no intervention and acts as a control group in the analyses but will receive rhythm and music therapy after one year, when the long-term follow-up is completed.
Other Names:
  • No intervention in phase one

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The main primary outcome measure is change in the degree of participation measured by the Stroke Impact Scale (SIS, version 2.0.).
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Based on the Classification of Functioning, Disability, and Health (ICF) the outcome measures are classified into 6 comprehensive domains, with participation being the primary outcome measure. Other primary outcome measures within the participation domain are Life satisfaction checklist, EuroQol and the psychosocial subscale of Fatigue Impact Scale.Outcomes will be analyzed in terms of change from baseline to three, six and nine months.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Self-reported fatigue assessed by Fatigue Impact Scale
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
The secondary outcome measures are grouped within the following domains: 1. Self-reported fatigue; 2. Body functions and structure; 3. Activity; 4. Environmental and; 5. Personal factors.Outcomes will be analyzed in terms of change from baseline to three, six and nine months.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Participation: Change in life satisfaction measured using the Life Satisfaction Checklist - LiSat-9
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Participation: Change in health-related quality of life is measured using the EuroQol (EQ-5D)
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Self-reported fatigue: Change in the impact of fatigue on common daily activities and on health-related quality of life is measured with the Fatigue Impact Scale (FIS).
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Perceived physical functioning: Change in optimistic self-beliefs to cope with a variety of difficult demands in life are assessed using the General Self-Efficacy Scale (GSES).
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Perceived mental functioning: Change in perceived mental functioning is assessed using the Montgomery-Åsberg Depression Rating Scale - self rate (MADRS-S)
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Cognitive function: Change in psycho-motor speed and selective attention is assessed using the Ruff 2 & 7 selective attention test.
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Cognitive function: Change in working memory assessed using the Letter-Number Sequencing (LNS) and the subtest Digit spanin Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Cognitive function: Change in alertness, simple psycho-motor speed and working memory is assessed using the computerized "Test for Attentional Performance" or TAP and TAP-M (mobility version)- battery.
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Cognitive function: Change in non-verbal learning - of visual patterns is evaluated by the Non-verbal Learning Test (NVLT) included in the computerized Vienna Test System.
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Cognitive function: Change in general cognitive level and of language, visuospatial function, memory, and attention is done using the BNI Screen for Higher Cerebral Functions (BNIS).
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Changes in experienced tiredness using a Visual Analogue Scale (VAS) pre-and post testing.
Time Frame: At baseline, post intervention and at 6 months after completion of the intervention period.
At baseline, post intervention and at 6 months after completion of the intervention period.
Body function: Change in upper limb function is determined using the Action Research Arm Test (ARAT).
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Body function: Change in grip strength is measured using a Grippit® instrument (AB Detektor, Göteborg, Sweden), a portable instrument designed for measuring isometric grip strength.
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Body structure: Change in the analyses of biomarkers, growth factors and inflammatory markers.
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Activity: Change in perceived confidence in task performance is measured with the Swedish modification of the Falls-Efficacy Scale - FES (S).
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Activity: Change in motor recovery is assessed using the Modified Motor Assessment Scale according to the Uppsala University hospital (M-MAS UAS).
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Activity: Change in balance is evaluated by two measures: 1) the Berg Balance Scale (BBS) and 2) (Bäckstrand, Dahlberg, and Liljenäs) BDL balance scale
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Activity: Change in mobility is measured by the Timed "up and Go" (TUG).
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
For this study's exploratory purpose both individual interview and focus groups methodology are used.
Time Frame: When treatment is finalized
When treatment is finalized
Activity: To measure gait speed the timed 10 meter walk test (10MWT) is used
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Activity: Change in walking capacity is measured using the 6-minute walk test (6MWT).
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Activity: Change in the level of dependence/independence in personal and instrumental activities of daily living among the participants is evaluated by the ADL Staircase.
Time Frame: Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Evaluation is conducted at baseline, following the 12-week intervention period, and six months after completion of the intervention period.
Environmental factors: Change in the life situation among the spouses is evaluated by the Life Situation among spouses after the Stroke event questionnaire (LISS).
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Personal factors: Change in the participants' ability to cope with stress is assessed using The Sense of Coherence (SOC) scale.
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
Activity: To measure gait speed the timed 10 meter walk test (10MWT) was used
Time Frame: At baseline, post intervention and at 3 and 6 months after completion of the intervention period.
At baseline, post intervention and at 3 and 6 months after completion of the intervention period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Christian Blomstrand, Professor, Göteborg University
  • Study Chair: Lina Bunketorp Kall, Ph. D., Göteborg University
  • Principal Investigator: Michael Nilsson, Professor, Göteborg University
  • Study Chair: Åsa Lundgren Nilsson, Ph. D., Göteborg University
  • Study Chair: Milos Pekny, Professor, Göteborg University
  • Study Chair: Marcela Pekna, Ass prof, Göteborg University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

May 30, 2014

Study Completion (Actual)

June 2, 2014

Study Registration Dates

First Submitted

May 26, 2011

First Submitted That Met QC Criteria

June 10, 2011

First Posted (Estimate)

June 13, 2011

Study Record Updates

Last Update Posted (Actual)

April 24, 2019

Last Update Submitted That Met QC Criteria

April 23, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on RGRM

3
Subscribe